4.7 Article

The influence of postscreening follow-up time and participant characteristics on estimates of overdiagnosis from lung cancer screening trials

Related references

Note: Only part of the references are listed.
Article Medicine, General & Internal

Estimation of Breast Cancer Overdiagnosis in a US Breast Screening Cohort

Marc D. Ryser et al.

Summary: This study estimated the rate of breast cancer overdiagnosis in contemporary mammography practice, finding that about 1 in 7 cases of screen-detected cancer is overdiagnosed under biennial screening.

ANNALS OF INTERNAL MEDICINE (2022)

Article Public, Environmental & Occupational Health

Prognostic selection and long-term survival analysis to assess overdiagnosis risk in lung cancer screening randomized trials

Eugenio Paci et al.

Summary: In low-dose computed tomography randomized screening trials, overdiagnosis rates vary widely. Long-term follow-up data from the National Lung Screening Trial and ITALUNG showed low or no overdiagnosis rates. A method used in previous assessments was applied to compute long-term survival rates in the ITALUNG trial, revealing no significant difference in cumulative incidence rates between active and control arms, with a higher proportion of resected and early cases in the active arm.

JOURNAL OF MEDICAL SCREENING (2021)

Article Oncology

Overdiagnosis in lung cancer screening: Estimates from the German Lung Cancer Screening Intervention Trial

Sandra Gonzalez Maldonado et al.

Summary: A study on lung cancer screening among long-term smokers revealed a risk of overdiagnosis in the screening group, especially for individuals with shorter life expectancies. The excess cumulative incidence in the screening arm was largely driven by adenocarcinomas, suggesting a major risk of overdiagnosis for individuals with comparatively short remaining life expectancies.

INTERNATIONAL JOURNAL OF CANCER (2021)

Article Critical Care Medicine

Overdiagnosis in lung cancer screening

Matthew E J Callister et al.

Lancet Respiratory Medicine (2021)

Review Medicine, General & Internal

Evaluation of the Benefits and Harms of Lung Cancer Screening With Low-Dose Computed Tomography Modeling Study for the US Preventive Services Task Force

Rafael Meza et al.

Summary: The study modeled the benefits and harms of LDCT screening for lung cancer, finding that starting at age 50 or 55 with a smoking history of 20 pack-years or more had more benefits compared to the 2013 USPSTF recommendations, but also resulted in more false-positive results, overdiagnosed cases, and radiation-related lung cancer deaths.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

Article Health Care Sciences & Services

Lung cancer mortality reduction by LDCT screening: UKLS randomised trial results and international meta-analysis

John K. Field et al.

Summary: The UKLS trial showed that a single LDCT screening can significantly reduce lung cancer mortality, with results similar to the NELSON and NLST trials. The meta-analysis of nine randomized trials provided unequivocal support for lung cancer screening in identified risk groups.

LANCET REGIONAL HEALTH-EUROPE (2021)

Article Oncology

Lung cancer mortality reduction by LDCT screening-Results from the randomized German LUSI trial

Nikolaus Becker et al.

INTERNATIONAL JOURNAL OF CANCER (2020)

Article Substance Abuse

Smoking Cessation in the ITALUNG Lung Cancer Screening: What Does Teachable Moment Mean?

Francesco Pistelli et al.

NICOTINE & TOBACCO RESEARCH (2020)

Article Medicine, General & Internal

Life-Gained-Based Versus Risk-Based Selection of Smokers for Lung Cancer Screening

Li C. Cheung et al.

ANNALS OF INTERNAL MEDICINE (2019)

Article Oncology

Lung Cancer Incidence and Mortality with Extended Follow-up in the National Lung Screening Trial

Denise R. Aberle et al.

JOURNAL OF THORACIC ONCOLOGY (2019)

Article Critical Care Medicine

Incorporating Coexisting Chronic Illness into Decisions about Patient Selection for Lung Cancer Screening An Official American Thoracic Society Research Statement

M. Patricia Rivera et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2018)

Article Medicine, General & Internal

Identifying Patients for Whom Lung Cancer Screening Is Preference-Sensitive A Microsimulation Study

Tanner J. Caverly et al.

ANNALS OF INTERNAL MEDICINE (2018)

Editorial Material Medicine, General & Internal

Accounting for the Harms of Lung Cancer Screening

Mark H. Ebell et al.

JAMA INTERNAL MEDICINE (2018)

Article Oncology

The impact of overdiagnosis on the selection of efficient lung cancer screening strategies

Summer S. Han et al.

INTERNATIONAL JOURNAL OF CANCER (2017)

Article Public, Environmental & Occupational Health

Conditions for Valid Empirical Estimates of Cancer Overdiagnosis in Randomized Trials and Population Studies

Roman Gulati et al.

AMERICAN JOURNAL OF EPIDEMIOLOGY (2016)

Article Critical Care Medicine

Results of the Randomized Danish Lung Cancer Screening Trial with Focus on High-Risk Profiling

Mathilde M. W. Wille et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2016)

Article Critical Care Medicine

Long-Term Follow-up Results of the DANTE Trial, a Randomized Study of Lung Cancer Screening with Spiral Computed Tomography

Maurizio Infante et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2015)

Editorial Material Public, Environmental & Occupational Health

Overdiagnosis in lung cancer screening: why modelling is essential

Kevin ten Haaf et al.

JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH (2015)

Article Medicine, General & Internal

Quantifying and monitoring overdiagnosis in cancer screening: a systematic review of methods

Jamie L. Carter et al.

BMJ-BRITISH MEDICAL JOURNAL (2015)

Article Medicine, General & Internal

Quantifying and monitoring overdiagnosis in cancer screening: a systematic review of methods

Jamie L. Carter et al.

BMJ-BRITISH MEDICAL JOURNAL (2015)

Article Medicine, General & Internal

Screening for Lung Cancer: US Preventive Services Task Force Recommendation Statement

Virginia A. Moyer

ANNALS OF INTERNAL MEDICINE (2014)

Article Medicine, General & Internal

Overdiagnosis in Low-Dose Computed Tomography Screening for Lung Cancer

Edward F. Patz et al.

JAMA INTERNAL MEDICINE (2014)

Article Medicine, General & Internal

Selection Criteria for Lung-Cancer Screening

Martin C. Tammemaegi et al.

NEW ENGLAND JOURNAL OF MEDICINE (2013)

Review Medicine, General & Internal

The benefits and harms of breast cancer screening: an independent review

M. G. Marmot et al.

LANCET (2012)

Article Medicine, General & Internal

Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening

Denise R. Aberle et al.

NEW ENGLAND JOURNAL OF MEDICINE (2011)

Article Computer Science, Interdisciplinary Applications

Conducting Meta-Analyses in R with the metafor Package

Wolfgang Viechtbauer

JOURNAL OF STATISTICAL SOFTWARE (2010)

Review Oncology

Overdiagnosis in Cancer

H. Gilbert Welch et al.

JOURNAL OF THE NATIONAL CANCER INSTITUTE (2010)

Article Oncology

Extended lung cancer incidence follow-up in the Mayo Lung Project and overdiagnosis

PM Marcus et al.

JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)

Article Mathematical & Computational Biology

Measuring explained variation in linear mixed effects models

RH Xu

STATISTICS IN MEDICINE (2003)